Showing results (51-60 of 57) with videos related to
Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 57 results.
Elife|January 11, 2022
Golden Syrian hamster as a model to study cardiovascular complications associated with SARS-CoV-2 infectionZaigham Abbas Rizvi, Rajdeep Dalal, Srikanth Sadhu, et al.International Immunopharmacology|October 14, 2021
The SARS CoV-2 spike directed non-neutralizing polyclonal antibodies cross-react with Human immunodeficiency virus (HIV-1) gp41Reshma Perween, Murugavelu PraveenKumar, Tripti Shrivastava, et al.International Immunopharmacology|August 24, 2021
Non-neutralizing SARS CoV-2 directed polyclonal antibodies demonstrate cross-reactivity with the HA glycans of influenza virusPraveenkumar Murugavelu, Reshma Perween, Tripti Shrivastava, et al.Frontiers in Immunology|February 6, 2025
CoviWall, a whole-virion-inactivated B.1.617.2 vaccine candidate, induces potent humoral and Th1 cell response in mice and protects against B.1.617.2 strain challenge in Syrian hamstersJyotsna Dandotiya, Neeta Adhikari, Manas Ranjan Tripathy, et al.The Lancet. Infectious Diseases|November 28, 2021
Effectiveness of ChAdOx1 nCoV-19 vaccine against SARS-CoV-2 infection during the delta (B.1.617.2) variant surge in India: a test-negative, case-control study and a mechanistic study of post-vaccination immune responsesRamachandran Thiruvengadam, Amit Awasthi, Guruprasad Medigeshi, et al.Plos Pathogens|April 28, 2022
A combination of potently neutralizing monoclonal antibodies isolated from an Indian convalescent donor protects against the SARS-CoV-2 Delta variantNitin Hingankar, Suprit Deshpande, Payel Das, et al.Plos Pathogens|December 12, 2022
A broadly neutralizing monoclonal antibody overcomes the mutational landscape of emerging SARS-CoV-2 variants of concernHilal Ahmad Parray, Naveen Narayanan, Sonal Garg, et al.Pageof 6